Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.

Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base.

Parvati Shallow and Rob Mariano competed on two seasons of "Survivor" together, first in 2010 and again in 2020.

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

The Boston Celtics' rocky midseason stretch continued on Monday with a last-second loss to the Houston Rockets, who got 10 ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

The Boston Celtics head to American Airlines Center to face the Dallas Mavericks in a non-conference matchup. The Celtics are ...

The Boston Celtics head to Intuit Dome to face the LA Clippers in a non-conference matchup. The Celtics are 30-13, which puts ...

The Celtics announced the team was being put up for sale last July, shortly after winning their 18th championship ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...